Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASCO Annual Meeting
Friday, June 2
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
1:00 PM – 3:15 PM
Location: Hall D1
EXTENDED EDUCATION SESSION: Biomarkers for Immunotherapy: An Illusion or a Reality?
Vamsidhar Velcheti, MD, Chair
1:40 PM – 2:00 PM
Location: Hall D1
Biomarkers for Immune-Related Toxicities
Vamsidhar Velcheti, MD – Chair
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients